Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Moreau

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
ACS Chemical Biology|July 6, 2022
Cell Morphological Profiling Enables High-Throughput Screening for PROteolysis TArgeting Chimera (PROTAC) Phenotypic SignatureMaria-Anna Trapotsi, Elizabeth Mouchet, Guy Williams, et al.
The Journal of Cell Biology|September 7, 2019
New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cellsLaia Bassaganyas, Stephanie J Popa, Max Horlbeck, et al.
Nature Communications|September 23, 2014
PICALM modulates autophagy activity and tau accumulationKevin Moreau, Angeleen Fleming, Sara Imarisio, et al.
Journal of Medicinal Chemistry|July 11, 2024
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate CancerSharan K Bagal, Peter C Astles, Coura Diène, et al.
Cell Reports|December 11, 2025
Cancer cells transfer invasive properties through microRNAs contained in collagen tracksLucile Rouyer, Léa Normand, Elodie Richard, et al.
Journal of Clinical and Experimental Hepatology|May 10, 2022
Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen MinipigsValérie Duvivier, Stéphanie Creusot, Olivier Broux, et al.
Journal of Medicinal Chemistry|December 11, 2025
Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular DegradersKhaled Essa, Natalia V Ortiz Zacarías, Sascha Roth, et al.
Physiological Reviews|October 21, 2010
Regulation of mammalian autophagy in physiology and pathophysiologyBrinda Ravikumar, Sovan Sarkar, Janet E Davies, et al.
Science (New York, N.Y.)|February 26, 2026
A cellular basis for the mammalian nocturnal-diurnal switchAndrew D Beale, Matthew J Christmas, Nina M Rzechorzek, et al.
Nature Communications|March 25, 2026
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degraderMonica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
ACS Chemical Biology|July 6, 2022
Cell Morphological Profiling Enables High-Throughput Screening for PROteolysis TArgeting Chimera (PROTAC) Phenotypic SignatureMaria-Anna Trapotsi, Elizabeth Mouchet, Guy Williams, et al.
The Journal of Cell Biology|September 7, 2019
New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cellsLaia Bassaganyas, Stephanie J Popa, Max Horlbeck, et al.
Nature Communications|September 23, 2014
PICALM modulates autophagy activity and tau accumulationKevin Moreau, Angeleen Fleming, Sara Imarisio, et al.
Journal of Medicinal Chemistry|July 11, 2024
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate CancerSharan K Bagal, Peter C Astles, Coura Diène, et al.
Cell Reports|December 11, 2025
Cancer cells transfer invasive properties through microRNAs contained in collagen tracksLucile Rouyer, Léa Normand, Elodie Richard, et al.
Journal of Clinical and Experimental Hepatology|May 10, 2022
Characterization and Pharmacological Validation of a Preclinical Model of NASH in Göttingen MinipigsValérie Duvivier, Stéphanie Creusot, Olivier Broux, et al.
Journal of Medicinal Chemistry|December 11, 2025
Leveraging Targeted Protein Degradation for G Protein-Coupled Receptors: The Development of CCR2 Molecular DegradersKhaled Essa, Natalia V Ortiz Zacarías, Sascha Roth, et al.
Physiological Reviews|October 21, 2010
Regulation of mammalian autophagy in physiology and pathophysiologyBrinda Ravikumar, Sovan Sarkar, Janet E Davies, et al.
Science (New York, N.Y.)|February 26, 2026
A cellular basis for the mammalian nocturnal-diurnal switchAndrew D Beale, Matthew J Christmas, Nina M Rzechorzek, et al.
Nature Communications|March 25, 2026
A dihydrouracil CRBN ligand mitigates IMiD associated safety liabilities in heterobifunctional targeted protein degraderMonica C Rodrigo-Brenni, Jasper C Komen, Ghaith M Hamza, et al.
Pageof 6